Harbin Medisan Pharmaceutical Co., Ltd, known as Harbin Medisan, is a nationwide enterprise specialized in the research and development, manufacturing, and sales of chemical pharmaceutical finished dosage forms and APIs. It possesses four wholly owned subsidiaries and one joint stock company, with a registered capital of 211 million Chinese Yuan. The company has a total of 13 production lines, with advanced technology and facilities.